However by correlating the differences between myofibre subtypes within each comparison (e.g. control type I ∼ type IIa vs. ACTA1‐type I ∼ TNNT1‐type IIa; Fig. 2O), we observed a reduction in fold change in NM disease, as highlighted in Fig. 2O. This evidence concerns the gene TNNT1 and nemaline myopathy.